AstraZeneca PLC (AZN.L)

LSE - LSE Delayed Price. Currency in GBp
4,614.50-162.50 (-3.40%)
At close: 12:05 PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close4,777.00
Bid4,500.00 x 6100
Ask5,100.00 x 13000
Day's Range4,502.00 - 4,956.64
52wk Range3,680.00 - 5,505.00
1y Target EstN/A
Market Cap58.37B
P/E Ratio (ttm)26.37
Avg Vol (3m)2,579,925
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Financial Times5 hours ago

    [$$] FDA deals blow to AstraZeneca cancer drug

    Drugmaker AstraZeneca's US-listed shares fell 4 per cent on Thursday after it announced that US regulators had dealt a setback to its prospective cancer drug durvalumab by placing a temporary halt on enrolling ...

  • The Wall Street Journal6 hours ago

    [$$] AstraZeneca Suspends Recruitment in Two Cancer Clinical Trials

    AstraZeneca PLC said it had suspended enrollment into two large clinical trials on head and neck cancer while it investigates whether the treatment is causing patients to bleed.

  • Financial Times7 hours ago

    [$$] AstraZeneca slides after cancer drug trial suspended

    AstraZeneca was a faller on Thursday on news it had suspended a trial of one of its most important pipeline drugs. Filings on, the US National Library of Medicine's public registry, ...